Skip to main content
. 2013 Oct 1;13(20):1–28.

Table 7: Sensitivity Analysis—Decreasing the sensitivity of the 13C UBT to 90.1%.

Total Incremental
Strategy Cost ($)/Test Misdiagnoses (FP +FN) Cost ($)/Test Misdiagnoses (FP +FN) Avoided ICER $/Misdiagnoses Avoided
ELISA serology $13.96 0.2236 Reference Reference Reference
13C UBTa $74.96 0.0888 $61.00 0.1348 $452
ELISA serology + 13C UBT $50.02 0.0662 $36.06 0.1574 $229

Abbreviations: 13C UBT, carbon-13 urea breath test; ELISA, enzyme-linked immunosorbent assay; FN, false-negative result; FP, false-positive result: ICER, incremental cost-effectiveness ratio.

a

13C UBT dominated by ELISA serology + 13C UBT (13C UBT more costly, fewer misdiagnoses avoided than ELISA + 13C UBT).